Description

Esmia (Ulipristal Acetate) Tablets 5 mg. №28

Ingredients

Each tablet contains 5 mg of ulipristal acetate as the active ingredient.

Dosage

The recommended dosage is one tablet orally, with or without food, as soon as possible within 120 hours (5 days) after unprotected intercourse or contraceptive failure.

Indications

Esmia tablets are indicated for emergency contraception to prevent pregnancy after unprotected intercourse or contraceptive failure.

Contraindications

Do not use Esmia if you are already pregnant, have severe asthma, or are allergic to ulipristal acetate or any other ingredients in the tablets.

Directions

Take one tablet orally with water as soon as possible after unprotected intercourse. Consult a healthcare provider for further guidance.

Scientific Evidence

Esmia (Ulipristal Acetate) tablets have been extensively studied for their efficacy and safety in preventing pregnancy after unprotected intercourse. Clinical trials have shown that ulipristal acetate is highly effective in reducing the risk of pregnancy when taken within the recommended time frame.

The pharmacological action of ulipristal acetate involves delaying or inhibiting ovulation, thereby preventing fertilization. It may also alter the endometrium, reducing the likelihood of implantation.

Compared to other emergency contraceptive options, ulipristal acetate has been shown to be more effective, especially when taken closer to the time of unprotected intercourse. It is well-tolerated with a favorable safety profile.